ERG and precursor B-cell acute lymphoblastic leukemia: To test the functional relevance of this element, we used CRISPRi to target the intron 3 region, which significantly reduced ERG expression and impaired growth of different B-ALL cell lines (Figure 7), with effects comparable to CRISPRi targeting the ERG promoter region.